
Bioventus Inc. / Financial strength (Piotroski F-Value) /
The F-Value, developed by Stanford accounting professor Joseph Piotroski, measures a company's financial strength based on nine distinct criteria. Piotroski suggest using the value as part of a value investing strategy to rank stocks with a low price-to-book ratio. The approach is described in detail in Piotroski's 2002 Paper Value Investing: The Use of Historical Financial Statement Information to Separate Winners From Losers.
You are viewing the F-Value as of . Click to view the current F-Value instead.
- Financial strength (Piotroski F-Value)
-
3
/ 9
- Return on assets (ROA) greater than 0
- close -11.6%
- Operating cash flow greater than 0
- close -$11.55M
- ROA greater than previous year
- close -11.6% ≤ 1.6%
- Cash flow return on assets (CFROA) greater than Return on assets (ROA)
- check -1.0% > -11.6%
- Leverage ratio lower than previous year
- check 28.0% < 28.9%
- Current ratio greater than previous year
- close 89.7% ≤ 145.5%
- No new common stock issued last year
- close $4.97M
- Gross margin greater than previous year
- close 64.6% ≤ 70.3%
- Asset turnover greater than previous year
- check 37.3% > 35.2%
F-Value history
The F-Value is calculated for each quarter based on the cumulation of the previous four quarterly statements. Click on the chart to see the F-Value at a specific time in the past.
-
7
-
3
-
5
-
4
-
4
-
2
-
2
-
1
-
3
-
4
-
4
-
4
-
4
-
5
-
6
-
6
-
6
-
5